SCHEMBL7410475

SCHEMBL7410475

NNC(=O)c1cccc(OCc2ccccc2)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 3/20 0.78
NR4A2 P43354 1/20 0.72
ALDH1A1 P00352 4/20 0.71
NPC1 O15118 4/20 0.71
RAB9A P51151 3/20 0.71
SMN1; SMN2 Q16637 3/20 0.71
MAPT P10636 2/20 0.70
MAOB P27338 1/20 0.68
NR1H4 Q96RI1 1/20 0.67
GPR132 Q9UNW8 1/20 0.66
PTPN1 P18031 1/20 0.66
GUSB P08236 1/20 0.64
MEN1 O00255 1/20 0.64
KMT2A Q03164 1/20 0.64
KDM4E B2RXH2 1/20 0.64
LMNA P02545 1/20 0.64
TP53 P04637 1/20 0.64
HTT P42858 1/20 0.64
SRD5A2 P31213 1/20 0.63
FAAH O00519 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1608032 0.88 SMPD1 (1.00) SMPD1NR4A2MAOBNR1H4GPR132
SCHEMBL16015339 0.88 MEN1 (0.71) SMPD1NR4A2ALDH1A1NPC1RAB9A
SCHEMBL31148956 0.88 ALDH1A1 (0.69) SMPD1NR4A2ALDH1A1NPC1RAB9A
SCHEMBL13702365 0.87 SMPD1 (0.76) SMPD1NR4A2RAB9AMAOBNR1H4
SCHEMBL21616251 0.85 SMPD1 (0.74) SMPD1NR4A2SMN1; SMN2MAOBNR1H4
SCHEMBL3442550 0.85 PTPN1 (0.75) SMPD1NR4A2MAOBNR1H4GPR132
SCHEMBL32665557 0.85 SPHK2 (0.83) SMPD1NR4A2NPC1RAB9AMAOB
SCHEMBL17894403 0.85 SMPD1 (0.69) SMPD1NR4A2RAB9AMAOBNR1H4
SCHEMBL1387246 0.84 NR4A2 (0.77) SMPD1NR4A2MAOBNR1H4PTPN1
SCHEMBL13702183 0.84 GPR132 (0.73) SMPD1NR4A2MAOBNR1H4GPR132

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107236106-A The aromatic series terminal hydroxy group chain extender of the key containing acylhydrazone, selfreparing polyurethane and preparation method thereof 青岛科技大学 2017-10-10 CN claimed
WO-2022180080-A1 ANTI-PROLIFERATIVE AGENTS FIRST HEALTH PHARMACEUTICALS B.V. (NL) 2022-09-01 WO disclosed
EP-4050002-A1 ANTI-PROLIFERATIVE AGENTS First Health Pharmaceuticals B.V. (NL) 2022-08-31 EP disclosed
CN-107236106-B Aromatic hydroxyl-terminated chain extender containing acylhydrazone bond, self-repairing polyurethane and preparation method of chain extender 青岛科技大学 2020-01-07 CN disclosed
CN-107236106-A The aromatic series terminal hydroxy group chain extender of the key containing acylhydrazone, selfreparing polyurethane and preparation method thereof 青岛科技大学 2017-10-10 CN disclosed
US-20110081297-A1 Novel Substituted Pyrazoles, 1,2,4-Oxadiazoles, and 1,3,4-Oxadiazoles MERCK & CO. INC. 2011-04-07 US disclosed
US-20110081297-A1 Novel Substituted Pyrazoles, 1,2,4-Oxadiazoles, and 1,3,4-Oxadiazoles MERCK & CO. INC. 2011-04-07 US disclosed
WO-2009146343-A1 NOVEL SUBSTITUTED PYRAZOLES, 1,2,4-OXADIAZOLES, AND 1,3,4-OXADIAZOLES MERCK & CO., INC. (US) 2009-12-03 WO disclosed
CN-1950374-A Tetraazabenzo[e]azulene derivatives and analogs thereof PFIZER (US) 2007-04-18 CN disclosed
EP-1079821-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2001-08-29 EP disclosed
EP-1079821-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-03-07 EP disclosed
WO-1999059570-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1999-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110081297-A1 Novel Substituted Pyrazoles, 1,2,4-Oxadiazoles, and 1,3,4-Oxadiazoles APP, PSEN1, BACE1 SMPD1 2045/4885NR4A2 541/4885ALDH1A1 1617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.